TP53 status predicts long-term survival in locally advanced breast cancer after primary chemotherapy

BACKGROUND: Before the advent of neoadjuvant chemotherapy, radiotherapy and surgery alone were associated with a high risk of uncontrolled locoregional relapses in locally advanced breast cancer (LABC). MATERIAL AND METHODS: In the 1990s we initiated two neoadjuvant protocols, where patients with LA...

Descripción completa

Detalles Bibliográficos
Autores principales: Eikesdal, Hans P., Knappskog, Stian, Aas, Turid, Lønning, Per E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245178/
https://www.ncbi.nlm.nih.gov/pubmed/24909504
http://dx.doi.org/10.3109/0284186X.2014.922215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245178/
https://www.ncbi.nlm.nih.gov/pubmed/24909504
http://dx.doi.org/10.3109/0284186X.2014.922215

Ejemplares similares